活动依赖的p25生成调节了突触可塑性和Aβ诱导的认知障碍
Jinsoo Seo1, Paola Giusti-Rodríguez1, Ying Zhou1
1The Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Cell
|April 15, 2014
概括
在神经元活动期间从p35产生的蛋白质p25在突触可塑性和记忆中发挥作用. 在阿尔茨海默病模型中,在小鼠中阻止p25的产生改善了认知功能.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 突触性可塑性 突触性可塑性
背景情况:
- 循环素依赖激酶5 (CDK5) 和它的激活剂p35对于神经元功能至关重要.
- 病态的p35分裂产生p25,与神经退行性疾病有关.
- 对于p25生产的生理作用仍然不清楚.
研究的目的:
- 为了研究神经元活动期间p25的生理生成.
- 阐明p25在突触可塑性,记忆和阿尔茨海默病 (AD) 病理学中的作用.
- 开发一种预防p25形成的遗传工具.
主要方法:
- 产生了一种具有抗卡尔巴因p35突变的克诺金小鼠模型 (Δp35KI).
- 在Δp35KI小鼠中评估突触可塑性 (长期抑郁) 和记忆丧失.
- 交叉 Δp35KI 小鼠与 5XFAD AD 模型小鼠,以评估 Aβ 诱导的病理.
主要成果:
- 在神经元活动中,p25在生理上以依赖于GluN2B和CaMKIIα的方式产生.
- Δp35KI小鼠表现出长期抑郁和记忆丧失的损伤,与持续的GluA1酸化有关.
- 将Δp35KI小鼠与5XFAD小鼠交叉治疗改善了Aβ诱导的突触抑郁和认知缺陷.
结论:
- p25的产生在突触可塑性和记忆形成中起着生理作用.
- 向p25生成可能为阿尔茨海默病和其他神经退行性疾病提供治疗效益.
- 这项研究为p25在正常突触过程和AD病变发生过程中的功能提供了新的见解.
相关概念视频
01:25Long-term Potentiation
2.7K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
2.7K
01:35Long-term Potentiation
51.6K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
51.6K
01:23Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
01:03Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K
01:05Long-term Depression
27.3K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
27.3K
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K